ClinicalTrials.gg
RecruitingNCT06515574Updated Oct 26, 2026

Effect of Developmental Care on Very Low Birth Weight Infants

An interventional study of developmental care in Intervention, sponsored by Children's Hospital of Fudan University. Recruiting at 2 sites in China. Open to participants aged 0 Days to 30 Days. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Children's Hospital of Fudan University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 2 months later.
Updated Oct 26, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,600
Allocation
Randomized
Ages
0 Days to 30 Days
Sex
All
01

Study summary

The goal of this clinical trial is to learn if developmental care works when implemented in very low birth weight infants. The main questions it aims to answer are:

  • Does developmental care shorten the length of hospital stay in the very low birth weight infants?
  • Does developmental care increase the opportunity of family centered care in the very low birth weight infants? The clinical trial will use a 36-month stepped-wedge cluster-randomised trial conducted across 40 Neonatal intensive care units . A developmental care bundle will be tailored to meet the identified needs of participating NICUs.
Read the detailed description

Developmental care in the NICU focuses on creating a nurturing environment that supports the physical, emotional, and developmental needs of premature infants. This approach includes strategies like minimizing unnecessary noise and light, ensuring appropriate positioning and handling of infants, promoting skin-to-skin contact, and facilitating parental involvement in care.

The clinical trial investigates the effectiveness of developmental care in very low birth weight (VLBW) infants. The primary objectives are to determine whether developmental care can (1) reduce the length of hospital stay and (2) enhance the opportunity for family-centered care in these infants. The study employs a 36-month stepped-wedge cluster-randomised trial design, involving 40 Neonatal Intensive Care Units (NICUs).

In this trial, all NICUs will eventually receive the intervention, but the order in which they start implementing the developmental care bundle will be randomized. This approach allows each NICU to serve as its own control, comparing outcomes before and after the intervention.

Data collection will occur at multiple time points before and after the implementation of the developmental care bundle, enabling a comprehensive analysis of its impact. By tailoring interventions to each NICU's specific context and needs, the study aims to generate robust evidence on the benefits of developmental care for VLBW infants and their families.

02

Conditions studied

  • Intervention

Keywords

  • developmental care
03

In context

Lead sponsor

Children's Hospital of Fudan University is the lead sponsor of 268 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 30 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Birth weights less than 1500 g
  2. Admitted or transported to a level III NICU within 24h of birth
  3. OI>30

Exclusion criteria

Exclusion Criteria:

  1. Severe congenital malformations
  2. various chromosomal disorders
  3. genetic metabolic diseases,
  4. severe neurological disorders
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
1,600 participants (estimated)

Study arms

  • Experimental
    Developmental care

    In stage 1, participant in this arm will receive the developmental care

    Behavioral: developmental care

  • No intervention
    Usual care

    Participant in this arm will receive the usual care

Interventions

  • Behavioraldevelopmental care

    Individualized Developmental Care that includes the light, noise, sleep, etc.

06

What researchers measure

Primary outcomes

  1. Length of hospital stay

    Length of hospital stay (in days)

    Time frame: From the day admitted into the NICU until day on discharge, generally assessed up to 1 year

Secondary outcomes

  1. Skin to skin care duration

    Skin-to-skin care, also known as kangaroo care, involves placing a newborn baby directly on a parent's bare chest. Record the duration of skin to skin care every day during the hospitalization by hours

    Time frame: From the day admitted into the NICU until day on discharge, generally assessed up to 1 year

Other outcomes

  1. Parental involvement duration

    Parental involvement in our study is defined as the parents take part in the daily Care Activities (diapering, bathing, clothing and feeding for their babies).Record the duration of parental involvement every day during the hospitalization by hours

    Time frame: From the day admitted into the NICU until day on discharge, generally assessed up to 1 year

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Unidentified individual participant data (including data dictionaries) will be made available, in addition to study protocols, the statistical analysis plan, the informed consent form and the related code. The data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to corresponding authors.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Aug 2024 (actual). Primary completion is estimated for Aug 2028, 48 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 26, 2026: primary completion Aug 2027 → Aug 2028 and completion Dec 2027 → Dec 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2024
First posted
Jul 23, 2024
StartActual
Aug 30, 2024
Primary completionEst.
Aug 30, 2028was Aug 2027
CompletionEst.
Dec 1, 2028was Dec 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 30, 2027→Aug 30, 2028
Oct 26, 2026
Study completion
Dec 1, 2027→Dec 1, 2028
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Primary completion Aug 30, 2027→Aug 30, 2028
    Study completion Dec 1, 2027→Dec 1, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06515574
Responsible party
Sponsor
First posted
Jul 23, 2024
Start date
Aug 30, 2024
Primary completion
Aug 30, 2028 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Oct 26, 2026

Study contacts

Lyu Tianchan
Contact
lvtianchan1988@aliyun.com
18017590870

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion